Latest editorial
High street chemist Boots has threatened a charity with legal action over a campaign urging the company to reduce the price of the morning-after pill for women, it was revealed yesterday.
The British Pregnancy Advisory Service (BPAS) launched its push for affordable emergency contraception last November, pointing out that nearly all the larger pharmacy firms have lowered the price to about £13.50.
Boots was charging £28.25 for Levonelle and £26.75 for its own generic version, which BPAS said was more than any of its major rivals charged.
As peers prepare to debate reform of the 1861 Offences Against the Person Act, Labour MP Tonia Antoniazzi leads a bid to end the criminalisation of women who end pregnancies at home. LYNNE WALSH reports
EDDIE DEMPSEY explains why the RMT is calling for urgent action against assaults on staff and passengers on our public transport system
Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS
